Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vlad Ratziu

Showing results (31-40 of 384) with videos related to

Pageof 39
Sort By:
Hepatology (Baltimore, Md.)|September 29, 2006
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get seriousVlad Ratziu, Thierry Poynard
Journal of Hepatology|January 5, 2023
Rational combination therapy for NASH: Insights from clinical trials and errorVlad Ratziu, Michael Charlton
Gastroenterologie Clinique Et Biologique|October 31, 2003
[Non-alcoholic steatosis: limits of current knowledge and lessons for hepatologists]Vlad Ratziu, Thierry Poynard
Alimentary Pharmacology & Therapeutics|August 16, 2019
Editorial: it is not a wide-open field for incretins - collateral benefits favour the use of metformin in advanced non-alcoholic steatohepatitisVlad Ratziu, Raluca Pais
La Revue Du Praticien|February 22, 2013
[Epidemiology and natural history of nonalcoholic fatty liver disease]Raluca Pais, Vlad Ratziu
Journal of Hepatology|December 24, 2024
Introducing the Updates in Clinical Science: A focus on recent data of high impactVlad Ratziu, Tom H Karlsen
Journal of Hepatology|February 15, 2015
Non-alcoholic fatty liver - perhaps not so benignLeon A Adams, Vlad Ratziu
Gastroenterology|May 23, 2020
Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?Vlad Ratziu, Scott L Friedman
Clinics in Liver Disease|October 13, 2009
Pharmacologic therapy of non-alcoholic steatohepatitisVlad Ratziu, Shira Zelber-Sagi
Journal of Gastrointestinal and Liver Diseases : JGLD|December 29, 2010
An overview of nonalcoholic steatohepatitis: past, present and future directionsAlina Pascale, Raluca Pais, Vlad Ratziu
Pageof 39

Showing results (31-40 of 384) with videos related to

Sort By:
Pageof 39
Hepatology (Baltimore, Md.)|September 29, 2006
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get seriousVlad Ratziu, Thierry Poynard
Journal of Hepatology|January 5, 2023
Rational combination therapy for NASH: Insights from clinical trials and errorVlad Ratziu, Michael Charlton
Gastroenterologie Clinique Et Biologique|October 31, 2003
[Non-alcoholic steatosis: limits of current knowledge and lessons for hepatologists]Vlad Ratziu, Thierry Poynard
Alimentary Pharmacology & Therapeutics|August 16, 2019
Editorial: it is not a wide-open field for incretins - collateral benefits favour the use of metformin in advanced non-alcoholic steatohepatitisVlad Ratziu, Raluca Pais
La Revue Du Praticien|February 22, 2013
[Epidemiology and natural history of nonalcoholic fatty liver disease]Raluca Pais, Vlad Ratziu
Journal of Hepatology|December 24, 2024
Introducing the Updates in Clinical Science: A focus on recent data of high impactVlad Ratziu, Tom H Karlsen
Journal of Hepatology|February 15, 2015
Non-alcoholic fatty liver - perhaps not so benignLeon A Adams, Vlad Ratziu
Gastroenterology|May 23, 2020
Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?Vlad Ratziu, Scott L Friedman
Clinics in Liver Disease|October 13, 2009
Pharmacologic therapy of non-alcoholic steatohepatitisVlad Ratziu, Shira Zelber-Sagi
Journal of Gastrointestinal and Liver Diseases : JGLD|December 29, 2010
An overview of nonalcoholic steatohepatitis: past, present and future directionsAlina Pascale, Raluca Pais, Vlad Ratziu
Pageof 39